Latest filings (excl ownership)
8-K
Submission of Matters to a Vote of Security Holders
13 Jun 24
8-K/A
Entry into a Material Definitive Agreement
7 Jun 24
8-K
Entry into a Material Definitive Agreement
6 Jun 24
10-Q
2024 Q1
Quarterly report
13 May 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
10-K
2023 FY
Annual report
15 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Feb 24
25-NSE
Exchange delisting
15 Feb 24
8-K
Unregistered Sales of Equity Securities
17 Jan 24
8-K
Unregistered Sales of Equity Securities
5 Jan 24
8-K
Unregistered Sales of Equity Securities
3 Jan 24
8-K
Unregistered Sales of Equity Securities
11 Dec 23
RW
Registration withdrawal request
1 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Nov 23
8-K
Entry into a Material Definitive Agreement
22 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
S-1/A
IPO registration (amended)
3 Nov 23
S-1/A
IPO registration (amended)
31 Oct 23
8-K
ZIVO Bioscience Announces Reverse Stock Split
26 Oct 23
S-1
IPO registration
4 Oct 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Aug 23
EFFECT
Notice of effectiveness
4 Aug 23
424B3
Prospectus supplement
3 Aug 23
CORRESP
Correspondence with SEC
1 Aug 23
UPLOAD
Letter from SEC
31 Jul 23
S-3
Shelf registration
27 Jul 23
D
$4.00 mm in options / securities to be acquired, sold $4.00 mm, 1 investor
17 Jul 23
8-K
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
6 Jul 23
424B5
Prospectus supplement for primary offering
5 Jul 23
RW
Registration withdrawal request
28 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
26 May 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
8-K
ZIVO Bioscience Receives $1 Million Bridge Financing
5 Apr 23
S-1
IPO registration
22 Mar 23
Latest ownership filings
4
Alison A Cornell
13 Jun 24
4
Christopher D. Maggiore
13 Jun 24
4
Nola E Masterson
13 Jun 24
SC 13D
Cornell Alison A
12 Jun 24
SC 13D
PAYNE JOHN BERNARD
12 Jun 24
SC 13D
Marchiando Keith
12 Jun 24
SC 13D/A
Maggiore Christopher D.
7 Jun 24
4
Christopher D. Maggiore
6 Jun 24
4
Nola E Masterson
6 Jun 24
4
Alison A Cornell
6 Jun 24
4
Keith Marchiando
6 Jun 24
4
JOHN BERNARD PAYNE
6 Jun 24
4
Alison A Cornell
4 Jun 24
SC 13D/A
STROME MEZZANINE FUND, LP
9 Apr 24
SC 13D
Maggiore Christopher D.
22 Jan 24
4
Alison A Cornell
4 Jan 24
4
Christopher D. Maggiore
2 Jan 24
4
Christopher D. Maggiore
14 Dec 23
4
MARK E STROME
30 Oct 23
SC 13D/A
STROME MEZZANINE FUND, LP
30 Oct 23
4
Alison A Cornell
14 Jun 23
4
Christopher D. Maggiore
14 Jun 23
4
Nola E Masterson
14 Jun 23
4
JOHN BERNARD PAYNE
5 Apr 23
4/A
Christopher D. Maggiore
14 Feb 23
SC 13D/A
Maggiore Christopher D.
14 Feb 23
4
Alison A Cornell
21 Dec 22
4
Nola E Masterson
21 Dec 22
4
JOHN BERNARD PAYNE
20 Dec 22
4
Christopher D. Maggiore
20 Dec 22
4
Alison A Cornell
20 Dec 22
4
JOHN BERNARD PAYNE
20 Dec 22
4
Nola E Masterson
20 Dec 22
4
Alison A Cornell
14 Dec 22
4/A
Nola E Masterson
8 Dec 22
4/A
Christopher D. Maggiore
8 Dec 22
4
Christopher D. Maggiore
19 Sep 22
4
Keith Marchiando
31 Aug 22
4
Alison A Cornell
1 Aug 22
4
Christopher D. Maggiore
1 Aug 22